Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 2 study of etrasimod in adults with eosinophilic esophagitis
NL-OMON52257Phase 2Active, not recruiting
- Sponsor
- Arena Pharmaceuticals, Inc.
- Start
- Feb 2021
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of etrasimod in eosinophilic esophagitis (EoE), sponsored by Arena Pharmaceuticals, Inc.. Started Feb 2021; status: active, not recruiting.
02
Drugs
etrasimod
03
Conditions
eosinophilic esophagitis (EoE)
Beyond the preview
Go deeper on NL-OMON52257.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON52257.